home / stock / thtx / thtx news

THTX News and Press, Theratechnologies Inc.

Stock Information
Company Name: Theratechnologies Inc.
Stock Symbol: THTX
Market: NYSE
Website: theratech.com
Menu
THTX THTX Quote THTX Short THTX News THTX Articles THTX Message Board
Get THTX Alerts

News, Short Squeeze, Breakout and More Instantly...
THTX - THTX Stock Earnings: Theratechnologies Beats EPS, Beats Revenue for Q2 2024

2024-07-10 12:52:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Theratechnologies (NASDAQ: THTX ) just reported results for the second quarter of 2024. Theratechnologies reported earnings per share of 2 cents. This was above the analys...
THTX - Theratechnologies Inc. (THTX) Q2 2024 Earnings Call Transcript

2024-07-10 10:05:28 ET Theratechnologies Inc. (THTX) Earnings Conference Call July 10, 2024 08:30 AM ET Company Participants John Leasure - Global Commercial Officer Paul Levesque - President & CEO Philippe Dubuc - SVP & CFO Christian Marsolais - SVP ...

THTX - Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024

Q2 revenue of $22 million represents +25% growth year-over-year Positive net income of $1 million realized with Adjusted EBITDA 1 of $5.5 million Fiscal 2024 revenue guidance confirmed between $87 and $90 million and an Adjusted EBITDA in the range of $13 to $15 mi...

THTX - Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update

MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will re...
THTX - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Poster highlights durable disease stabilization lasting beyond treatment completion Results suggest a unique, multimodal mechanism of action that differs from other cancer therapeutics Favorable tolerability sets stage for Part 3 (dose optimization) of Phase 1 trial, already u...

THTX - Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting

First long-term data presentation from Parts 1 and 2 of the Phase 1 clinical trial of sudocetaxel zendusortide in solid tumors Part 3 of Phase 1 trial in advanced ovarian cancer is ongoing MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechno...

THTX - Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders

MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company h...
THTX - Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

MONTREAL, April 11, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company&#...

THTX - Theratechnologies Inc. (THTX) Q1 2024 Earnings Call Transcript

2024-04-10 10:47:02 ET Theratechnologies Inc. (THTX) Q1 2024 Earnings Conference Call April 10, 2024 08:30 AM ET Company Participants Julie Schneiderman - Senior Director, Communications & Corporate Affairs Paul Levesque - President & CEO Philippe Dubuc -...

THTX - Theratechnologies GAAP EPS of -$0.10 beats by $0.04, revenue of $16.2M misses by $3.19M

2024-04-10 07:32:35 ET More on Theratechnologies Theratechnologies Inc. (THTX) Q4 2023 Earnings Call Transcript Theratechnologies stock plunges after FDA denies review of Trogarzo sBLA Theratechnologies says FDA rejected new Egrifta version Seeking Alpha ...
Next 10